NovoCure Ltd. (NVCR) PT Raised to $42 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Price: $17.38 -1.19%
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
11 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Emily Bodnar raised the price target on NovoCure Ltd. (NASDAQ: NVCR) to $42.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- JPMorgan Downgrades Denso Corp. (6902:JP) (DNZOY) to Underweight
- STAAR Surgical (STAA) PT Lowered to $28 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
